“The Utility of a Model-Based Cost-Effectiveness Analysis of Degarelix Versus Leuprolide in the Therapy of Hormone-Dependent Advanced Prostate Cancer”. 2013. Farmeconomia. Health Economics and Therapeutic Pathways 14 (3): 131-46. https://doi.org/10.7175/fe.v14i3.700.